| drug name | Sculptra (poly-L-lactic acid) |
| classification | Dermal filler |
| pharmacokinetics | Poly-L-lactic acid is a biocompatible material that is gradually absorbed by the body over a period of several years. The degradation is slow and progressive, leading to a sustained volume restoration effect. The precise pharmacokinetic details are not fully characterized in a typical patient-specific manner, as the material is integrated into the tissues rather than having a systemic distribution. |
| suggested dosage | Dosage is determined by the treating physician based on the desired aesthetic result and the patient's individual needs. It's not a one-size-fits-all approach. The amount injected and the frequency of treatment are variable. |
| indications | Used to correct facial wrinkles and folds, and to restore volume loss in the face (e.g., cheeks, temples, nasolabial folds). |
| safety in pregnancy | Sculptra is *not* recommended for use during pregnancy. Limited data exist, and there are theoretical concerns about potential effects on the developing fetus. The decision to use the drug should be made cautiously and in consultation with a healthcare professional. |
| safety in breastfeeding | Sculptra is *not* recommended for use during breastfeeding. Limited data exist, and there are theoretical concerns about potential effects on the infant. The decision to use the drug should be made cautiously and in consultation with a healthcare professional. |
| side effects | | 1 | Swelling | | 2 | Redness | | 3 | Bruising | | 4 | Pain | | 5 | Infection | | 6 | Hard lumps (nodules) | | 7 | Irritation | | 8 | Asymmetry | | 9 | Allergic reaction (though rare with poly-L-lactic acid) | | 10 | Numbness or tingling at the injection site |
|
| alternatives | |
| contraindications | | 1 | Known allergy to poly-L-lactic acid or other components of the filler | | 2 | Uncontrolled inflammatory conditions at the injection site | | 3 | Active infections near the intended injection area | | 4 | Bleeding disorders | | 5 | History of keloid scarring |
|
| interactions | Limited drug interactions are expected with poly-L-lactic acid. However, informing the healthcare provider about all medications being taken is essential. |
| warnings and precautions | | 1 | Injection site reactions are common, but more serious adverse events are rare. | | 2 | The results are gradual and may not be apparent immediately. | | 3 | The treatment is not permanent; the effect will eventually fade over time. | | 4 | Avoid strenuous activity for 24-48 hours after treatment. | | 5 | Do not touch or massage the injection site excessively. | | 6 | Consult your doctor for any unusual symptoms following treatment. | | 7 | There may be a need for multiple sessions to achieve the desired outcome. |
|
| additional informations | | 1 | Individual responses vary. The physician will assess the patient's needs and medical history. | | 2 | Patient age and weight are generally considered less important factors compared to overall health and individual response to treatment when considering Sculptra. However, a thorough medical history will be essential | | 3 | This information is for general knowledge only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your treatment. | | 4 | Results are highly variable. The final outcome and patient response to treatment must be evaluated by the healthcare professional. |
|
| patient profile | |
